Cargando…
Structure Driven Design of Novel Human Ether-A-Go-Go-Related-Gene Channel (hERG1) Activators
One of the main culprits in modern drug discovery is apparent cardiotoxicity of many lead-candidates via inadvertent pharmacologic blockade of K(+), Ca(2+) and Na(+) currents. Many drugs inadvertently block hERG1 leading to an acquired form of the Long QT syndrome and potentially lethal polymorphic...
Autores principales: | Guo, Jiqing, Durdagi, Serdar, Changalov, Mohamed, Perissinotti, Laura L., Hargreaves, Jason M., Back, Thomas G., Noskov, Sergei Y., Duff, Henry J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156305/ https://www.ncbi.nlm.nih.gov/pubmed/25191697 http://dx.doi.org/10.1371/journal.pone.0105553 |
Ejemplares similares
-
Role of the pH in state-dependent blockade of hERG currents
por: Wang, Yibo, et al.
Publicado: (2016) -
Lipid regulation of hERG1 channel function
por: Miranda, Williams E., et al.
Publicado: (2021) -
Rehabilitating drug-induced long-QT promoters: In-silico design of hERG-neutral cisapride analogues with retained pharmacological activity
por: Durdagi, Serdar, et al.
Publicado: (2014) -
Determinants of Isoform-Specific Gating Kinetics of hERG1 Channel: Combined Experimental and Simulation Study
por: Perissinotti, Laura L., et al.
Publicado: (2018) -
Improved functional expression of recombinant human ether-a-go-go (hERG) K(+ )channels by cultivation at reduced temperature
por: Chen, Mao Xiang, et al.
Publicado: (2007)